Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04956861 · ClinicalTrials.gov registry record · NA
HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction
A NA study, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT04956861 is a NA study that has completed, run by University of Colorado, Boulder. The registered enrollment target is 88 participants.
The verdict
NCT04956861, a NA study, has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
The investigators hypothesize that chronic insufficient sleep is associated with diminished endothelium-dependent nitric oxide-mediated vasodilation and tissue-type plasminogen activator release in anti-retroviral (ART)-treated HIV-1-seropositive adults. Furthermore, the investigators hypothesize that the postulated diminishment in endothelial vasodilator and fibrinolytic function with insufficient sleep will be due, at least in part, to increased oxidative stress. Moreover, increasing sleep duration and improving sleep quality will increase both endothelium-dependent nitric oxide-mediated vasodilation and endothelial tissue-type plasminogen activator release in ART-treated HIV-1-seropositive adults. Increases in endothelial vasodilator and fibrinolytic function will be due, at least in part, to reduced oxidative stress.
Interventions
- BEHAVIORAL Individualized Targeted Sleep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2015-12-17 |
| Est. Completion | 2020-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04956861
The ClinicalTrials.gov registry entry for NCT04956861 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Individualized Targeted Sleep is the first listed.
NCT04956861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04956861 about?
NCT04956861 is a clinical study titled "HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction". The investigators hypothesize that chronic insufficient sleep is associated with diminished endothelium-dependent nitric oxide-mediated vasodilation and tissue-type plasminogen activator release in anti-retroviral (ART)-treated HIV-1-seropositive adults. Furthermore, the investigators hypothesize th...
What is the current status of trial NCT04956861?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2015-12-17. Estimated completion is 2020-08-07.
What interventions are being tested in trial NCT04956861?
The interventions under investigation include: Individualized Targeted Sleep (BEHAVIORAL).
Who is sponsoring clinical trial NCT04956861?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.